|
BALTIMORE, MD—September 4, 2014—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), invites oncologists to read the CME-certified online publication, The Evolving State of the Art for the Management of Advanced Gastric Cancer: Emerging Science and Expert Perspectives.
Gastric cancer is often not diagnosed until it has progressed to an advanced, incurable stage. Because of this dismal prognosis, and a shortage of current standard-of-care regimens, there are wide practice variations among oncologists who manage this condition. Currently, several clinical trials investigating molecularly targeted therapies, alone and in combination with chemotherapy, are either underway or drawing to completion. As new evidence emerges on novel treatment approaches, oncologists strive to stay abreast of that evidence to better help manage their patients with advanced gastric cancer.
“This educational activity is designed to enhance oncologists’ understanding of the clinical rationale for the development of novel targeted agents in advanced gastric cancer,” said Charles S. Fuchs, MD, MPH, professor of medicine at the Harvard Medical School in Boston, MA. “It also highlights various ways in which recent therapeutic advances may be best incorporated into patient care as they become available.”
FACULTY
 |
|
Charles S. Fuchs, MD, MPH
Chief, Division of Gastrointestinal Oncology
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, MA
|
Clinicians are invited to visit www.Med-IQ.com/a728 for complimentary access to this educational opportunity, which expires on September 16, 2014. For more information, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit lillygrantoffice.com.
For more information, call (toll-free) 866 858 7434 or e-mail info@med-iq.com.
|
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management to improve team performance and patient outcomes. These initiatives have achieved improvements in healthcare provider performance, quality of care, and patient outcomes. Med-IQ's work in performance and quality education and training has been published 27 times in peer-reviewed journals, and the company has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
|
close
